June 12, 2024

MicroRNA Market Size To Rake USD 7,757.01 Mn By 2032

The global microRNA market size was valued at USD 1,252.80 million in 2022 and is projected to reach USD 7,757.01 million by 2032, growing at a CAGR of 20% from 2023 to 2032, According to Precedence Research.

MicroRNA Market Size 2023 To 2032

The global microRNA market boons an in-depth synopsis of the competitive landscape of the market globally, thus helping establishments understand the primary threats and prospects that players/vendors in the market are dealt with. It also incorporates thorough business profiles of some of the prime vendors in the market.

Download The Sample Copy For Better Understanding@ https://www.precedenceresearch.com/sample/3023

MicroRNA Market Report Scope

Report Coverage Details
Market Size in 2023 USD 1,503.36 Million
Market Size by 2032 USD 7,757.01 Million
Growth Rate from 2023 to 2032 CAGR of 20%
Largest Market North America
Fastest Growing Market Asia Pacific
Base Year 2022
Forecast Period 2023 to 2032
Segments Covered By Products, By Services, By Application, and By End Use
Regions Covered North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa

Also read: Sequencing Reagents Market Size To Rake USD 13.43 Bn By 2032

Benefits of this market

  • This study analyses the market size and share for microRNA along with the present trends in the industry and forecasts for the future, showing investment opportunities for the future.
  • In order to compare the financial capabilities of the microRNA market in the present, a quantitative analysis is done of the market from 2023 to 2032.
  • It is clear from this brilliant presentation of Porter’s Five Forces that buyers and suppliers have a lot of potential to gain from one another.
  • It is important to understand the most profitable trends in the microRNA market in order to gain an advantage in the market.
  • A comprehensive analysis of the driving factors, limitations, and opportunities is provided in the report, along with an in-depth analysis of the effect they have on the market.
  • The report also includes the market share for microRNA for several significant vendors as well as the latest developments in the market.

Leading players of the global microRNA market are analysed taking into account their market share, recent developments, new product launches, partnerships, mergers or acquisitions, and markets served. Precedence Research provide an exhaustive analysis of their product portfolios to explore the products and applications they concentrate on when operating in the global microRNA market. Furthermore, the report offers two separate market forecasts – one for the production side and another for the consumption side of the global microRNA market. It also provides useful recommendations for new as well as established players of the global microRNA market.

The major players in the market

  • Merck KGaA
  • QIAGEN
  • Thermo Fisher Scientific Inc.
  • Synlogic
  • GeneCopoeia, Inc
  • Horizon Discovery Ltd.
  • New England Biolabs
  • Quantabio
  • NanoString
  • BioGenex
  • SeqMatic LLC
  • Miltenyi Biotec
  • Agilent Technologies, Inc
  • Promega Corporation
  • Abcam plc
  • KANEKA CORPORATION

MicroRNA Market Segmentations:

By Products

  • Instruments
  • Consumables

By Services

  • Service Type
    • Isolation & Purification
    • miRNA cDNA Synthesis
    • Profiling, Localization, & Quantification
    • Functional Analysis
      • Real Time PCR
      • Microarray
      • NGS
      • Others
  • Specimen
    • Whole Blood
    • Serum
    • Plasma
    • FFPE
    • Fresh Frozen Tissue
    • Others

By Application

  • Cancer
  • Infectious Diseases
  • Immunological Disorder
  • Cardiovascular Disease
  • Neurological Disease
  • Others

By End Use

  • Biotechnology & Pharmaceutical Companies
  • Academic & Government Research Institutes
  • Other end-users

By Geography

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on MicroRNA Market 

5.1. COVID-19 Landscape: MicroRNA Industry Impact

5.2. COVID 19 – Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global MicroRNA Market, By Products

8.1. MicroRNA Market Revenue and Volume Forecast, by Products, 2023-2032

8.1.1. Instruments

8.1.1.1. Market Revenue and Volume Forecast (2020-2032)

8.1.2. Consumables

8.1.2.1. Market Revenue and Volume Forecast (2020-2032)

Chapter 9. Global MicroRNA Market, By Services

9.1. MicroRNA Market Revenue and Volume Forecast, by Services, 2023-2032

9.1.1. Service Type

9.1.1.1. Market Revenue and Volume Forecast (2020-2032)

9.1.2. Specimen

9.1.2.1. Market Revenue and Volume Forecast (2020-2032)

Chapter 10. Global MicroRNA Market, By Application 

10.1. MicroRNA Market Revenue and Volume Forecast, by Application, 2023-2032

10.1.1. Cancer

10.1.1.1. Market Revenue and Volume Forecast (2020-2032)

10.1.2. Infectious Diseases

10.1.2.1. Market Revenue and Volume Forecast (2020-2032)

10.1.3. Immunological Disorder

10.1.3.1. Market Revenue and Volume Forecast (2020-2032)

10.1.4. Cardiovascular Disease

10.1.4.1. Market Revenue and Volume Forecast (2020-2032)

10.1.5. Neurological Disease

10.1.5.1. Market Revenue and Volume Forecast (2020-2032)

10.1.6. Others

10.1.6.1. Market Revenue and Volume Forecast (2020-2032)

Chapter 11. Global MicroRNA Market, By End Use 

11.1. MicroRNA Market Revenue and Volume Forecast, by End Use, 2023-2032

11.1.1. Biotechnology & Pharmaceutical Companies

11.1.1.1. Market Revenue and Volume Forecast (2020-2032)

11.1.2. Academic & Government Research Institutes

11.1.2.1. Market Revenue and Volume Forecast (2020-2032)

11.1.3. Other end-users

11.1.3.1. Market Revenue and Volume Forecast (2020-2032)

Chapter 12. Global MicroRNA Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Volume Forecast, by Products (2020-2032)

12.1.2. Market Revenue and Volume Forecast, by Services (2020-2032)

12.1.3. Market Revenue and Volume Forecast, by Application (2020-2032)

12.1.4. Market Revenue and Volume Forecast, by End Use (2020-2032)

12.1.5. U.S.

12.1.5.1. Market Revenue and Volume Forecast, by Products (2020-2032)

12.1.5.2. Market Revenue and Volume Forecast, by Services (2020-2032)

12.1.5.3. Market Revenue and Volume Forecast, by Application (2020-2032)

12.1.5.4. Market Revenue and Volume Forecast, by End Use (2020-2032)

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Volume Forecast, by Products (2020-2032)

12.1.6.2. Market Revenue and Volume Forecast, by Services (2020-2032)

12.1.6.3. Market Revenue and Volume Forecast, by Application (2020-2032)

12.1.6.4. Market Revenue and Volume Forecast, by End Use (2020-2032)

12.2. Europe

12.2.1. Market Revenue and Volume Forecast, by Products (2020-2032)

12.2.2. Market Revenue and Volume Forecast, by Services (2020-2032)

12.2.3. Market Revenue and Volume Forecast, by Application (2020-2032)

12.2.4. Market Revenue and Volume Forecast, by End Use (2020-2032)

12.2.5. UK

12.2.5.1. Market Revenue and Volume Forecast, by Products (2020-2032)

12.2.5.2. Market Revenue and Volume Forecast, by Services (2020-2032)

12.2.5.3. Market Revenue and Volume Forecast, by Application (2020-2032)

12.2.5.4. Market Revenue and Volume Forecast, by End Use (2020-2032)

12.2.6. Germany

12.2.6.1. Market Revenue and Volume Forecast, by Products (2020-2032)

12.2.6.2. Market Revenue and Volume Forecast, by Services (2020-2032)

12.2.6.3. Market Revenue and Volume Forecast, by Application (2020-2032)

12.2.6.4. Market Revenue and Volume Forecast, by End Use (2020-2032)

12.2.7. France

12.2.7.1. Market Revenue and Volume Forecast, by Products (2020-2032)

12.2.7.2. Market Revenue and Volume Forecast, by Services (2020-2032)

12.2.7.3. Market Revenue and Volume Forecast, by Application (2020-2032)

12.2.7.4. Market Revenue and Volume Forecast, by End Use (2020-2032)

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Volume Forecast, by Products (2020-2032)

12.2.8.2. Market Revenue and Volume Forecast, by Services (2020-2032)

12.2.8.3. Market Revenue and Volume Forecast, by Application (2020-2032)

12.2.8.4. Market Revenue and Volume Forecast, by End Use (2020-2032)

12.3. APAC

12.3.1. Market Revenue and Volume Forecast, by Products (2020-2032)

12.3.2. Market Revenue and Volume Forecast, by Services (2020-2032)

12.3.3. Market Revenue and Volume Forecast, by Application (2020-2032)

12.3.4. Market Revenue and Volume Forecast, by End Use (2020-2032)

12.3.5. India

12.3.5.1. Market Revenue and Volume Forecast, by Products (2020-2032)

12.3.5.2. Market Revenue and Volume Forecast, by Services (2020-2032)

12.3.5.3. Market Revenue and Volume Forecast, by Application (2020-2032)

12.3.5.4. Market Revenue and Volume Forecast, by End Use (2020-2032)

12.3.6. China

12.3.6.1. Market Revenue and Volume Forecast, by Products (2020-2032)

12.3.6.2. Market Revenue and Volume Forecast, by Services (2020-2032)

12.3.6.3. Market Revenue and Volume Forecast, by Application (2020-2032)

12.3.6.4. Market Revenue and Volume Forecast, by End Use (2020-2032)

12.3.7. Japan

12.3.7.1. Market Revenue and Volume Forecast, by Products (2020-2032)

12.3.7.2. Market Revenue and Volume Forecast, by Services (2020-2032)

12.3.7.3. Market Revenue and Volume Forecast, by Application (2020-2032)

12.3.7.4. Market Revenue and Volume Forecast, by End Use (2020-2032)

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Volume Forecast, by Products (2020-2032)

12.3.8.2. Market Revenue and Volume Forecast, by Services (2020-2032)

12.3.8.3. Market Revenue and Volume Forecast, by Application (2020-2032)

12.3.8.4. Market Revenue and Volume Forecast, by End Use (2020-2032)

12.4. MEA

12.4.1. Market Revenue and Volume Forecast, by Products (2020-2032)

12.4.2. Market Revenue and Volume Forecast, by Services (2020-2032)

12.4.3. Market Revenue and Volume Forecast, by Application (2020-2032)

12.4.4. Market Revenue and Volume Forecast, by End Use (2020-2032)

12.4.5. GCC

12.4.5.1. Market Revenue and Volume Forecast, by Products (2020-2032)

12.4.5.2. Market Revenue and Volume Forecast, by Services (2020-2032)

12.4.5.3. Market Revenue and Volume Forecast, by Application (2020-2032)

12.4.5.4. Market Revenue and Volume Forecast, by End Use (2020-2032)

12.4.6. North Africa

12.4.6.1. Market Revenue and Volume Forecast, by Products (2020-2032)

12.4.6.2. Market Revenue and Volume Forecast, by Services (2020-2032)

12.4.6.3. Market Revenue and Volume Forecast, by Application (2020-2032)

12.4.6.4. Market Revenue and Volume Forecast, by End Use (2020-2032)

12.4.7. South Africa

12.4.7.1. Market Revenue and Volume Forecast, by Products (2020-2032)

12.4.7.2. Market Revenue and Volume Forecast, by Services (2020-2032)

12.4.7.3. Market Revenue and Volume Forecast, by Application (2020-2032)

12.4.7.4. Market Revenue and Volume Forecast, by End Use (2020-2032)

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Volume Forecast, by Products (2020-2032)

12.4.8.2. Market Revenue and Volume Forecast, by Services (2020-2032)

12.4.8.3. Market Revenue and Volume Forecast, by Application (2020-2032)

12.4.8.4. Market Revenue and Volume Forecast, by End Use (2020-2032)

12.5. Latin America

12.5.1. Market Revenue and Volume Forecast, by Products (2020-2032)

12.5.2. Market Revenue and Volume Forecast, by Services (2020-2032)

12.5.3. Market Revenue and Volume Forecast, by Application (2020-2032)

12.5.4. Market Revenue and Volume Forecast, by End Use (2020-2032)

12.5.5. Brazil

12.5.5.1. Market Revenue and Volume Forecast, by Products (2020-2032)

12.5.5.2. Market Revenue and Volume Forecast, by Services (2020-2032)

12.5.5.3. Market Revenue and Volume Forecast, by Application (2020-2032)

12.5.5.4. Market Revenue and Volume Forecast, by End Use (2020-2032)

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Volume Forecast, by Products (2020-2032)

12.5.6.2. Market Revenue and Volume Forecast, by Services (2020-2032)

12.5.6.3. Market Revenue and Volume Forecast, by Application (2020-2032)

12.5.6.4. Market Revenue and Volume Forecast, by End Use (2020-2032)

Chapter 13. Company Profiles

13.1. Merck KGaA

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. QIAGEN

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. Thermo Fisher Scientific Inc.

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. Synlogic

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. GeneCopoeia, Inc

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. Horizon Discovery Ltd.

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. New England Biolabs

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. Quantabio

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. NanoString

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. BioGenex

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms

Key inquiries addressed in the report:

  • Investigate the COVID 19 outbreak’s effects.
  • Our researchers give precise responses, pinpoint significant chances and fresh investments, and suggest excellent market strategy avenues.

About Us

Precedence Research is a Canada/India based company and one of the leading providers of strategic market insights. We offer executive-level blueprints of markets and solutions beyond flagship surveys. Our repository covers consultation, syndicated market studies, and customized research reports. Through our services we aim at connecting an organization’s goal with lucrative prospects globally.

From gauging investment feasibility to uncovering hidden growth opportunities, our market studies cover in-depth analysis, which also is interspersed with relevant statistics. Recommendation are often enclosed within our reports with the sole intent of enabling organizations achieve mission-critical success.

Contact Us:                  

Precedence Research

Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada

Call: +1 9197 992 333

Email: sales@precedenceresearch.com

Website: https://www.precedenceresearch.com

Blog: https://www.pharma-geek.com

Leave a Reply

Your email address will not be published. Required fields are marked *